[HTML][HTML] A comparative study of the plasma chemokine profile in COVID-19 patients infected with different SARS-CoV-2 variants

ZR Korobova, NA Arsentieva, NE Liubimova… - International Journal of …, 2022 - mdpi.com
Background. Infection caused by SARS-CoV-2 mostly affects the upper and lower
respiratory tracts and causes symptoms ranging from the common cold to pneumonia with …

[HTML][HTML] Cytokine profiling in different SARS-CoV-2 genetic variants

ZR Korobova, NA Arsentieva, NE Liubimova… - International Journal of …, 2022 - mdpi.com
This study is a successor of our previous work concerning changes in the chemokine profile
in infection that are associated with different SARS-CoV-2 genetic variants. The goal of our …

Effect of chemokine gene variants on Covid-19 disease severity

S Dogan, SZ Mart Komurcu, MD Korkmaz… - Immunological …, 2022 - Taylor & Francis
Patients immune phenotype/genotype data may be useful to understand the molecular
mechanisms involved in SARS-CoV-2 infection and can contribute to the identify the …

[HTML][HTML] CXCL8, CCL2, and CMV seropositivity as new prognostic factors for a severe COVID-19 course

E Pius-Sadowska, A Niedźwiedź, P Kulig… - International Journal of …, 2022 - mdpi.com
The exact pathophysiology of severe COVID-19 is not entirely elucidated, but it has been
established that hyperinflammatory responses and cytokine storms play important roles. The …

Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China

Y Chi, Y Ge, B Wu, W Zhang, T Wu… - The Journal of …, 2020 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the …

[HTML][HTML] Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling

X Xi, Y Guo, M Zhu, Y Wei, G Li, B Du, Y Wang - Virology journal, 2021 - Springer
Background Chemokine levels in severe coronavirus disease 2019 (COVID-19) patients
have been shown to be markedly elevated. But the role of chemokines in mild COVID-19 …

[HTML][HTML] Chemokines and chemokine receptors during COVID-19 infection

BA Khalil, NM Elemam, AA Maghazachi - Computational and structural …, 2021 - Elsevier
Chemokines are crucial inflammatory mediators needed during an immune response to
clear pathogens. However, their excessive release is the main cause of hyperinflammation …

Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity

E Cuesta-Llavona, J Gómez, GM Albaiceta… - International …, 2021 - Elsevier
The chemokine receptor CCR5 has been implicated in COVID-19. CCR5 and its ligands are
overexpressed in patients. The pharmacological targeting of CCR5 would improve the …

[HTML][HTML] Dynamic changes in circulatory cytokines and chemokines levels in mild to severe COVID-19 patients

V Tiwari, J Agarwal, AK Pathak, S Singh - Indian Journal of Clinical …, 2023 - Springer
Immune dysregulation is a key feature of the coronavirus disease-2019 (COVID-19).
However, disparities in responses across ethnic groups are underappreciated. This study …

Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity

I Trifonova, K Ngoc, M Nikolova… - International …, 2023 - journals.sagepub.com
Objectives Cytokine dysregulation has been proposed as one of the main culprits for severe
COVID-19 and poor prognosis. We examined the parallel presence of lymphopoietic …